Advertisement

Sarcomatoid carcinoma in the sinonasal cavity: A retrospective case series from a single institution

  • Author Footnotes
    1 These authors contributed equally.
    Zhenzhen Zhu
    Footnotes
    1 These authors contributed equally.
    Affiliations
    Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally.
    Lei Wang
    Footnotes
    1 These authors contributed equally.
    Affiliations
    Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    Search for articles by this author
  • Weiqing Wang
    Affiliations
    Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    Search for articles by this author
  • Yang Zha
    Affiliations
    Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    Search for articles by this author
  • Xiaowei Wang
    Affiliations
    Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    Search for articles by this author
  • Jinbo Han
    Affiliations
    Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    Search for articles by this author
  • Wei Lv
    Correspondence
    Corresponding author. Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, No.1, Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Affiliations
    Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally.
Published:February 16, 2022DOI:https://doi.org/10.1016/j.anl.2022.01.005

      Abstract

      Objectives

      Sarcomatoid carcinoma (SC) is rare in the sinonasal cavity with poor prognosis. This study aimed to summarize the clinical characteristics, treatment and prognosis of patients with sinonasal SC from a single tertiary medical center.

      Methods

      Retrospective review of the clinical data of seven patients diagnosed with sinonasal SC from May 1988 to February 2021.

      Results

      Seven patients with SC in nasal cavity and paranasal sinus, including six males and one female, aged 34-77 years (mean, 58.3 years), were included in this case series. The common presenting symptoms included epistaxis and nasal obstruction. The tumor usually occurred in nasal cavity, maxillary sinus and ethmoid sinus. Most patients were diagnosed at advanced stages with the involvement of orbit and skull base. Open and endoscopic surgery were performed in five and two patients, respectively. The follow-up period ranged from 3 to 26 months. Four patients died of disease within one year, though two received adjuvant chemotherapy and one received radiotherapy. Two patients survived without recurrence at the end of follow-up, both of them underwent adjuvant radiotherapy. One patient received palliative re-irradiation due to local recurrence of the tumor three months after the surgery, however, this patient was lost to follow-up.

      Conclusions

      Sinonasal SC is a rare entity with an aggressive behavior and poor prognosis. Early diagnosis and multimodality treatment are recommended to improve the survival.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Auris Nasus Larynx
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shindo ML
        • Stanley Jr, RB
        • Kiyabu MT
        Carcinosarcoma of the nasal cavity and paranasal sinuses.
        Head Neck. 1990; 12: 516-519
        • Xu Z
        • Wang L
        • Tu L
        • Liu Y
        • Xie X
        • Tang X
        • et al.
        Epidemiology of and prognostic factors for patients with sarcomatoid carcinoma: a large population-based study.
        Am J Cancer Res. 2020; 10: 3801-3814
        • de Souza Cruz EL
        • de Moraes ATL
        • de Souza Neves Filho F
        • Carneiro Junior JT
        • Cruz ESBT
        • Montalli VAM
        • et al.
        A rare case of invasive sinonasal carcinosarcoma.
        Int J Surg Case Rep. 2020; 70: 243-248
        • EI-Naggar AK
        • Chan JKC
        • Grandis JR
        • Takata T
        • Slootweg PJ.
        WHO Classification of Head and Neck Tumours.
        4th edition. IARC Press, Lyon, France2017
        • Viswanathan S
        • Rahman K
        • Pallavi S
        • Sachin J
        • Patil A
        • Chaturvedi P
        • et al.
        Sarcomatoid (spindle cell) carcinoma of the head and neck mucosal region: a clinicopathologic review of 103 cases from a tertiary referral cancer centre.
        Head Neck Pathol. 2010; 4: 265-275
        • Gerry D
        • Fritsch VA
        • Lentsch EJ.
        Spindle cell carcinoma of the upper aerodigestive tract: an analysis of 341 cases with comparison to conventional squamous cell carcinoma.
        Ann Otol Rhinol Laryngol. 2014; 123: 576-583
        • Alem HB
        • AlNoury MK.
        Management of spindle cell carcinoma of the maxillary sinus: a case report and literature review.
        Am J Case Rep. 2014; 15: 454-458
        • Yuen J
        • Varadarajan V
        • Stavrakas M
        • Muquit S
        • Khalil H.
        A Case of Invasive Sinonasal Carcinosarcoma: The Importance of Early Detection.
        Case Rep Otolaryngol. 2018; 20182745973
        • Liu TW
        • Hung SH
        • Chen PY.
        Sinonasal spindle cell carcinoma presenting with bilateral visual loss: A case report and review of the literature.
        Oncol Lett. 2016; 12: 401-404
        • Doshi DV
        • Tripathi U
        • Dave RI
        • Pandya SJ
        • Shukla HK
        • Parikh BC.
        Rare tumors of sinonasal track.
        Indian J Otolaryngol Head Neck Surg. 2010; 62: 111-117
        • Patel TD
        • Vazquez A
        • Plitt MA
        • Baredes S
        • Eloy JA.
        A case-control analysis of survival outcomes in sinonasal carcinosarcoma.
        Am J Otolaryngol. 2015; 36: 200-204
        • Choi HR
        • Sturgis EM
        • Rosenthal DI
        • Luna MA
        • Batsakis JG
        • El-Naggar AK.
        Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas.
        Am J Surg Pathol. 2003; 27: 1216-1220
        • Schaefer IM
        • Schweyer S
        • Kuhlgatz J.
        Chromosomal imbalances in primary hepatic carcinosarcoma.
        Hum Pathol. 2012; 43: 1328-1333
        • Thompson L
        • Chang B
        • Barsky SH
        Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis.
        Am J Surg Pathol. 1996; 20: 277-285
        • Zidar N
        • Gale N
        • Kojc N
        • Volavsek M
        • Cardesa A
        • Alos L
        • et al.
        Cadherin-catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck.
        Virchows Arch. 2008; 453: 267-274
        • Zidar N
        • Bostjancic E
        • Gale N
        • Kojc N
        • Poljak M
        • Glavac D
        • et al.
        Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck–hallmark of epithelial-mesenchymal transition.
        Hum Pathol. 2011; 42: 482-488
        • Kojc N
        • Zidar N
        • Gale N
        • Poljak M
        • Fujs Komlos K
        • Cardesa A
        • et al.
        Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck.
        Virchows Arch. 2009; 454: 549-555
        • Ando M
        • Saito Y
        • Morikawa T
        • Omura G
        • Kobayashi K
        • Akashi K
        • et al.
        Maxillary carcinosarcoma: Identification of a novel MET mutation in both carcinomatous and sarcomatous components through next generation sequencing.
        Head Neck. 2015; 37: E179-E185
        • Zhang L
        • Chen L
        • Xiao M
        • Xie X
        • Wang F.
        Locally advanced undifferentiated sarcomatoid carcinoma of the right maxillary sinus with PDCD6-TERT fusion: A rare case report.
        Oral Oncol. 2021; 105466
        • Alotaiby F
        • Islam MN
        • Bhattacharyya I
        • Cohen DM
        • Drew PA
        • Lai J.
        Carcinosarcoma Arising from Inverted Papilloma in a Patient with History of Radiotherapy for Sinonasal Squamous Cell Carcinoma.
        Am J Case Rep. 2020; 21e921827
        • Choi KY
        • Amit M
        • Tam S
        • Bell D
        • Phan J
        • Garden AS
        • et al.
        Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies.
        Laryngoscope. 2021; 131 (E1468-E75)
        • Hasnaoui J
        • Anajar S
        • Tatari M
        • Abada R
        • Rouadi S
        • Roubal M
        • et al.
        Carcinosarcoma of the maxillary sinus: A rare case report.
        Ann Med Surg (Lond). 2017; 19: 41-44
        • Guan M
        • Li Y
        • Shi ZG
        • Xie LS
        • Cao XL.
        Sarcomatoid carcinoma involving the nasal cavity and paranasal sinus: a rare and highly progressive tumor.
        Int J Clin Exp Pathol. 2014; 7: 4489-4492
        • Vazquez A
        • Khan MN
        • Blake DM
        • Patel TD
        • Baredes S
        • Eloy JA.
        Sinonasal squamous cell carcinoma and the prognostic implications of its histologic variants: a population-based study.
        Int Forum Allergy Rhinol. 2015; 5: 85-91
        • Benninger MS
        • Kraus D
        • Sebek B
        • Tucker HM
        • Lavertu P.
        Head and neck spindle cell carcinoma: an evaluation of current management.
        Cleve Clin J Med. 1992; 59: 479-482
        • Moon JK
        • Kim AY
        • Chang DS
        • Park KY.
        Carcinosarcoma of the maxillary sinus.
        Clin Exp Otorhinolaryngol. 2013; 6: 114-116
        • Ding L
        • Bi ZF
        • Yuan H
        • Zhao XH
        • Guan XD
        • Yao HR
        • et al.
        Sarcomatoid Carcinoma in the Head and Neck: A Population-Based Analysis of Outcome and Survival.
        Laryngoscope. 2021; 131 (E489-E99)
        • Hacking S
        • Chavarria H
        • Jin C
        • Perry A
        • Nasim M
        Landscape of Immune Checkpoint Inhibition in Carcinosarcoma (MMMT): Analysis of IDO-1, PD-L1 and PD-1.
        Pathol Res Pract. 2020; 216152847
        • Kucukgoz Gulec U
        • Kilic Bagir E
        • Paydas S
        • Guzel AB
        • Gumurdulu D
        • Vardar MA
        Prognostic significance of programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in uterine carcinosarcoma.
        Eur J Obstet Gynecol Reprod Biol. 2020; 244: 51-55
        • Kim S
        • Kim MY
        • Koh J
        • Go H
        • Lee DS
        • Jeon YK
        • et al.
        Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.
        Eur J Cancer. 2015; 51: 2698-2707
        • Domblides C
        • Leroy K
        • Monnet I
        • Mazieres J
        • Barlesi F
        • Gounant V
        • et al.
        Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma.
        J Thorac Oncol. 2020; 15: 860-866
        • Zhao L
        • Yang Y
        • Gao Q.
        Efficacy and safety of nivolumab plus apatinib in advanced liver carcinosarcoma: a case report.
        Immunotherapy. 2019; 11: 651-656
        • Valter A
        • Roosipuu R
        • Tamm H
        • Padrik P.
        An anaplastic lymphoma kinase (ALK) fusion oncogene positive metastatic sarcomatoid carcinoma of the lung with good response to crizotinib.
        AME Case Rep. 2018; 2: 2
        • Chen X
        • Zhang Y
        • Lu J
        • Xu C
        • Liang J
        • Wang F
        • et al.
        Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor.
        Transl Oncol. 2017; 10: 115-120
        • Kim SM
        • Kim MJ
        • Jung HA
        • Sun JM
        • Choi YL
        • Ko YH
        • et al.
        Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series.
        Head Neck. 2015; 37: E66-E69